Seven $1 billion-plus drugs seen reaching market in 2016

LONDON, Feb 3 (Reuters) - Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1 billion-plus annual sales potential, led by new treatments for liver disease and HIV, according to a Thomson Reuters analysis.